JPH04273000A - Powdery or granular enzyme preparation which contains protease as working enzyme and does not contain surface active agent, and enzymatic softening agent and bating agent which contain the preparation - Google Patents
Powdery or granular enzyme preparation which contains protease as working enzyme and does not contain surface active agent, and enzymatic softening agent and bating agent which contain the preparationInfo
- Publication number
- JPH04273000A JPH04273000A JP3291064A JP29106491A JPH04273000A JP H04273000 A JPH04273000 A JP H04273000A JP 3291064 A JP3291064 A JP 3291064A JP 29106491 A JP29106491 A JP 29106491A JP H04273000 A JPH04273000 A JP H04273000A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- preparation
- enzyme preparation
- agent
- contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 53
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 53
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 239000004365 Protease Substances 0.000 title claims abstract description 31
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims abstract 5
- 230000002255 enzymatic effect Effects 0.000 title claims description 9
- 239000003795 chemical substances by application Substances 0.000 title claims description 8
- 239000004094 surface-active agent Substances 0.000 title description 5
- 239000004902 Softening Agent Substances 0.000 title 1
- 229920001864 tannin Polymers 0.000 claims abstract description 21
- 239000001648 tannin Substances 0.000 claims abstract description 21
- 235000018553 tannin Nutrition 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims abstract description 7
- 235000011130 ammonium sulphate Nutrition 0.000 claims abstract description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 claims abstract description 5
- 235000011152 sodium sulphate Nutrition 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 2
- 239000004067 bulking agent Substances 0.000 claims 1
- 239000010985 leather Substances 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 230000001376 precipitating effect Effects 0.000 abstract description 2
- 239000004606 Fillers/Extenders Substances 0.000 abstract 3
- 239000002131 composite material Substances 0.000 abstract 2
- 238000002791 soaking Methods 0.000 abstract 2
- 102000035195 Peptidases Human genes 0.000 description 36
- 229940088598 enzyme Drugs 0.000 description 36
- 238000000034 method Methods 0.000 description 20
- 238000001556 precipitation Methods 0.000 description 14
- 235000019833 protease Nutrition 0.000 description 12
- 235000019419 proteases Nutrition 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000013142 Amylases Human genes 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- 229940079919 digestives enzyme preparation Drugs 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000002797 proteolythic effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241000235395 Mucor Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 239000002351 wastewater Substances 0.000 description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000228251 Aspergillus phoenicis Species 0.000 description 2
- 241001112078 Aspergillus usamii Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 241000235527 Rhizopus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000222354 Trametes Species 0.000 description 2
- 229940025131 amylases Drugs 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000005115 demineralization Methods 0.000 description 2
- 230000002328 demineralizing effect Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 241000484419 Aedia Species 0.000 description 1
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 241000532370 Atla Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000606215 Bacteroides vulgatus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000221756 Cryphonectria parasitica Species 0.000 description 1
- 241000660443 Encyclops Species 0.000 description 1
- 241001246273 Endothia Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000235525 Rhizomucor pusillus Species 0.000 description 1
- 241000433831 Rhopalosiphum rufiabdominalis Species 0.000 description 1
- 241000015473 Schizothorax griseus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000187438 Streptomyces fradiae Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 238000006887 Ullmann reaction Methods 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 150000005676 cyclic carbonates Chemical class 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- BCAARMUWIRURQS-UHFFFAOYSA-N dicalcium;oxocalcium;silicate Chemical compound [Ca+2].[Ca+2].[Ca]=O.[O-][Si]([O-])([O-])[O-] BCAARMUWIRURQS-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012990 dithiocarbamate Chemical class 0.000 description 1
- 150000004659 dithiocarbamates Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- -1 sorbitan fatty acid esters Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C1/00—Chemical treatment prior to tanning
- C14C1/06—Facilitating unhairing, e.g. by painting, by liming
- C14C1/065—Enzymatic unhairing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C1/00—Chemical treatment prior to tanning
- C14C1/04—Soaking
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C1/00—Chemical treatment prior to tanning
- C14C1/08—Deliming; Bating; Pickling; Degreasing
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、皮革製造で皮の柔軟化
、酵解及び脱毛用の作用酵素としてのプロテアーゼを含
有する、界面活性剤不含の固体酵素製剤に関し、これは
タンニン沈澱により得られる。FIELD OF INDUSTRIAL APPLICATION The present invention relates to a surfactant-free solid enzyme preparation containing a protease as an active enzyme for softening, fermentation and depilation of leather in leather production. can get.
【0002】0002
【従来の技術】タンニン沈澱法は、かなり前から溶液、
例えば植物液汁又は水性培地から酵素を単離する場合に
しばしば使用されている方法である。これには、比較的
広い範囲の公知技術が存在する[例えば、英国特許(G
B−C)第1156900号明細書、西ドイツ特許(D
E−A)第1642619号明細書]。その際、その目
的は一般に、酵素の精製である。良好な沈澱のための保
証手段としては、ゼラチンの添加又は酸性pH範囲(p
H3〜5)における操作が挙げられる。しかし、タンニ
ンは続く酵素精製で破壊される(最後には一緒に沈澱さ
せられる酵素と不溶性の複合体を形成する)ので、再び
除去せねばならず、これは大抵は沈澱を有機溶剤、例え
ばアセトン又はエタノールで処理することによって行わ
れるか又は界面活性剤の添加によってか又はタンニン沈
澱でpH値を高めることによって行われる:これらの手
段は一般に実験室規模でだけ著しい複雑さなしに行うこ
とができるにすぎない。[Prior Art] The tannin precipitation method has been used for quite some time using solutions,
For example, this is a method often used to isolate enzymes from plant sap or aqueous media. There is a relatively wide range of known technology for this [e.g.
B-C) No. 1156900, West German Patent (D
E-A) No. 1642619]. The purpose is generally the purification of the enzyme. Guarantees for good precipitation include the addition of gelatin or the acidic pH range (p
Examples include operations in H3-5). However, the tannins are destroyed in the subsequent enzyme purification (eventually forming an insoluble complex with the enzymes with which they are precipitated) and have to be removed again, usually by removing the precipitate with an organic solvent, e.g. acetone. or by treatment with ethanol or by addition of surfactants or by increasing the pH value with tannin precipitation: these measures can generally be carried out without significant complications only on a laboratory scale. It's nothing more than that.
【0003】タンニン複合体自体の工業的使用は、若干
の場合に少し記載されている。即ち、タンニン複合体を
脱脂乳と一緒に乾燥させることによって、安定なα−ア
ミラーゼ−製剤に加工する(CS141233)。医学
的に使用するために、膵臓をタンニン酸で沈澱させるこ
とによって製造された不溶性膵臓製剤が準備されている
。この製剤は酸性の胃液中に不溶性であるが、アルカリ
性の胃部分でその作用を発揮する(西ドイツ特許第12
8419号明細書)。The industrial use of tannin complexes as such has been sparsely described in some cases. That is, by drying the tannin complex together with skim milk, it is processed into a stable α-amylase preparation (CS141233). For medical use, insoluble pancreatic preparations are prepared by precipitating the pancreas with tannic acid. This preparation is insoluble in the acidic gastric juices, but exerts its action in the alkaline stomach region (West German Patent No. 12
8419 specification).
【0004】その他に、西ドイツ特許(DE−A)第2
143945号明細書には、特にタンニン複合体の形の
“水に不溶の、皮膚に相容性の乾燥酵素−付加物”が記
載されている。実際に使用するためには、例えば、タン
ニン沈澱法から得られた細菌−プロテイナーゼの付加物
を直接洗浄剤粉末中に配合混入する。タンニン−複合体
は十分に洗浄作用を有するので、使用時に、即ち洗浴中
で“消失(aufgegangen)”しうる。[0004] In addition, West German Patent (DE-A) No. 2
No. 143,945 describes "water-insoluble, skin-compatible dry enzyme adducts", in particular in the form of tannin complexes. For practical use, for example, the bacteria-proteinase adduct obtained from the tannin precipitation method is incorporated directly into the detergent powder. The tannin complexes have a sufficient cleaning action so that they can be "disappeared" during use, ie in the washing bath.
【0005】[0005]
【発明が解決しようとする課題】前記公知技術から、水
性環境中からの酵素のタンニン沈澱法は使用可能な沈澱
方法ではあるが、この沈澱した酵素−タンニン−複合体
を工業的に使用することは、−前記例外は除いて−予想
される使用条件下での相対的安定性が邪魔になっている
と思われる。[Problems to be Solved by the Invention] From the above-mentioned known techniques, although the method of tannin precipitation of an enzyme from an aqueous environment is a usable precipitation method, it is difficult to use the precipitated enzyme-tannin complex industrially. - with the exceptions noted above - it appears to be hampered by relative stability under the expected conditions of use.
【0006】皮革製造で固体の酵素製剤、特に酵解−及
び柔軟製剤として使用するためのプロテイナーゼ含有の
製剤を製造するために、これまで主として膵臓搾出汁又
は細菌培養液からの硫酸アンモニウム又は硫酸ナトリウ
ムを用いる沈澱が使用された[Ullmanns E
ncyclopadie der technis
chen Chemie、第4版、第10巻、475
〜561頁、495頁以降、Verlag Chem
ie、1975年、西ドイツ特許(DE−A)第223
4412号明細書参照]。In order to produce solid enzyme preparations in leather production, in particular proteinase-containing preparations for use as fermentation and softening preparations, ammonium sulfate or sodium sulfate, mainly from pancreatic juice or bacterial cultures, have so far been used. The precipitate used was [Ullmanns E
cyclopadie der technis
Chen Chemie, 4th edition, Volume 10, 475
〜Page 561, from page 495, Verlag Chem
ie, 1975, West German Patent (DE-A) No. 223
4412].
【0007】しかし、この方法は−特に生態学的見地か
ら−決して理想的でなく、一般に廃水の非常に著しい負
荷を必然的に伴う。これは、酵素含有液1001当り沈
澱させるために硫酸アンモニウム50kgが必要である
ことを意味する、常用の大ざっぱな原則から明かである
。このような塩量は、硫酸塩負荷をできる限り制限する
廃水管理の現在の潮流に反する。特に皮革工業が極めて
厳しい費用面の制限下で操業することを考えに入れて、
むしろ、廃水負荷が実質的に僅かであり、つまり費用の
面からも有利であるような効率のよい酵素−沈澱法の開
発に努められている。However, this method is by no means ideal - especially from an ecological point of view - and generally entails a very significant load of waste water. This is clear from the usual rule of thumb, which means that 50 kg of ammonium sulphate are required for precipitation per 100 kg of enzyme-containing liquid. Such salt levels run counter to current trends in wastewater management that limit sulfate loads as much as possible. Especially bearing in mind that the leather industry operates under extremely severe cost constraints,
On the contrary, efforts are being made to develop efficient enzyme-precipitation processes which have a substantially lower wastewater load and are thus also cost-effective.
【0008】[0008]
【課題を解決するための手段】さて、本発明によるプロ
テイナーゼ製剤EPが技術の前記の要求を極めてよく満
たすことが判明した。本発明は、作用酵素としてプロテ
アーゼを含有する(主として)界面活性剤不含の固体の
、即ち粉末状又は顆粒状の酵素製剤EPに関し、この製
剤は、水性環境中に存在する作用酵素を、酵素製剤が1
種又は数種の増量剤として常用の塩少なくとも50重量
%、有利には80重量%〜99.9重量%までから成る
ような程度でタンニンを添加することにより沈澱させる
ことによってタンニン複合体として得られるものである
。It has now been found that the proteinase preparation EP according to the invention satisfies the above-mentioned requirements of the technology very well. The present invention relates to (mainly) surfactant-free solid, i.e. powdered or granular, enzyme preparations EP containing proteases as active enzymes, which preparations contain proteases present in an aqueous environment. 1 formulation
Obtained as a tannin complex by precipitation by addition of tannins in an amount consisting of at least 50% by weight, advantageously from 80% to 99.9% by weight of salts customary as fillers or fillers. It is something that can be done.
【0009】本発明による“タンニン”とは、一般に天
然起源のこの名称で総括されるポリフェノール類、特に
タンニン酸である。詳細は、“ウルマンのエンツィクロ
ペディー デル テヒニッシェン ヒェミー(U
llmann Encyclopaedie de
r Technischen Chemie)第3
版、第11巻、593〜594頁;カーク−オスマー(
Kirk−Othmer)のエンサイクロペディア
オブ ケミカル テクノロジー(Encyclop
aedia of ChemicalTechno
logy)第2版、第12巻、319〜325頁、J.
Wiley、1967年、ツエヒマイスター(Zech
meister)のHersg.Fortschrit
te der Chemie organisc
her Naturstoffe、第41巻、4〜4
6(SpringerVerlag)に記載されている
。"Tannins" according to the invention are generally polyphenols of natural origin and summarized under this name, in particular tannic acid. For more information, please refer to “Ullmann's Enziklopedie der Technischen Chemie”
llmann encyclopedia de
r Technischen Chemie) 3rd
Edition, Volume 11, pp. 593-594; Kirk-Othmer (
Kirk-Othmer's Encyclopedia
of chemical technology (Encyclop)
aedia of Chemical Technology
2nd edition, Vol. 12, pp. 319-325, J.
Wiley, 1967, Zechmeister
Hersg. Fortschrit
te der Chemie organisc
her Naturstoffe, Volume 41, 4-4
6 (Springer Verlag).
【0010】“プロテアーゼ”とは、E.C.3.4.
に総括されている酵素である。"Protease" refers to E. C. 3.4.
These enzymes are summarized in
【0011】(Kirk−Othmer、Encycl
opaedie of Chemical Te
chnology、第3版、第9巻、173−223;
J.Wiley1980;E.Pfleiderer、
R.Reiner in H.J.Rehm &
G.Reed、Biotechnology、6b
巻、729−742、VCH1988;K.Aunst
rup、B.Spencer Ed.Industr
ial Aspectsof of Bioch
emistry、第30巻(I)、pp.23−46、
North Holland、1974参照)。(Kirk-Othmer, Encycle
opaedie of Chemical Te
Chnology, 3rd edition, Volume 9, 173-223;
J. Wiley1980;E. Pfleiderer,
R. Reiner in H. J. Rehm &
G. Reed, Biotechnology, 6b
Volume, 729-742, VCH1988; K. Aunst
rup, B. Spencer Ed. Industry
ial Aspects of Bioch
emistry, Volume 30 (I), pp. 23-46,
(See North Holland, 1974).
【0012】種々の分類基準があるが、その中には起源
による分類がある:
a) 動物起源、例えば、
α) レンニン(E.C.3.4.23.4)β)
膵臓−プロテアーゼ
パンクレアチン、特にトリプシン、キモトリプシン(p
H−作用範囲約7〜10)、ペプシン(E.C.3.4
.23.1)(pH−作用範囲約1.5〜4.0)、カ
セプシン(E.C.3.4.23.5)(作用範囲約4
.0〜5.0)
b) 植物起源
α) パパイン(E.C.3.4.22.1)pH−
作用範囲約5.0〜8.0
β) フィチン(E.C.3.4.22.3)pH−
作用範囲約4.0〜9.0
γ) ブロメライン(E.C.3.4.22.4及び
3.4.22.5)pH−作用範囲約5.0〜7.0c
) 微生物起源(L.Keay “Process
Biochemistry”1971年;17〜2
1年)
α) 桿菌類
例えば、枯草菌(B.subtilis)、B.レヒェ
ニホルミス(B.licheniformis)、B.
アルカロフィルス(B.alkalophilus)、
B.セレウス(B.cereus)B.ナットー(B.
Natto)、B.ブルガッス(B.vulgatus
)、根状菌(B.mycoides)
β) 連鎖球菌
γ) ストレプトマイセス類
例えば、ストレプトマイセス フラジアエ(Stre
ptomyces fradiae)、S.グリセウ
ス(S.griseus)、S.レクッス(S.rac
tus)
δ) アスペルギルス類
例えば、アスペルギルス フラブス−オリザエ(As
pergillus flavus−oryzae)
、黒色こうじ菌(A.niger)、クロカビ(A.s
aitoi)、A.ウサミイ(A.usamii)
ε) ケカビ類及びクモノスカビ類
例えばムコル プシルス(Mucor pusil
lus)、M.ミエヘイ(M.miehei)
ζ) エンドシア類
例えばエンドシア パラシチカ(Endothia
parasitica)
η) トラメテス類
例えばトラメテス サングイニア(Trametas
sanguinea)
起源による相違の他に、攻撃場所による相違(外−対内
酵素)及びプロテアーゼの“作用場所”による相違(D
FPにより抑制される血清−プロテアーゼ、スルフヒド
リル酵素)も使用される。There are various classification criteria, among them classification by origin: a) Animal origin, for example α) Rennin (E.C. 3.4.23.4) β)
Pancreatic - protease pancreatin, especially trypsin, chymotrypsin (p
H-Action range approx. 7-10), Pepsin (E.C. 3.4)
.. 23.1) (pH - range of action approximately 1.5 to 4.0), cathepsin (E.C. 3.4.23.5) (range of action approximately 4
.. 0-5.0) b) Plant origin α) Papain (EC3.4.22.1) pH-
Range of action approximately 5.0-8.0 β) Phytin (EC3.4.22.3) pH-
Range of action approximately 4.0-9.0 γ) Bromelain (E.C. 3.4.22.4 and 3.4.22.5) pH-range of action approximately 5.0-7.0c
) Microbial origin (L.Key “Process
Biochemistry”1971;17-2
1 year) α) Bacilli such as B. subtilis, B. B. licheniformis, B. licheniformis;
B. alkalophilus,
B. B. cereus Natto (B.
Natto), B. B. vulgatus
), B. mycoides β) Streptococcus γ) Streptomyces, such as Streptomyces fradiae
ptomyces fradiae), S. S. griseus, S. Recus (S. rac
tus) δ) Aspergillus species, such as Aspergillus flavus oryzae (As
pergillus flavus-oryzae)
, A. niger, A. s
aitoi), A. A. usamii ε) Mucor and spider molds such as Mucor pusil
lus), M. M. miehei ζ) Endothia such as Endothia parasitica
parasitica) η) Trametes such as Trametes sanguinia (Trametas sanguinia)
sanguinea) In addition to differences due to origin, there are also differences due to location of attack (exo-vs. endoenzyme) and differences due to “site of action” of proteases (D
Serum proteases inhibited by FP (sulfhydryl enzymes) are also used.
【0013】更に、酵素活性のpH依存性は実施する上
で非常に重要である。従って、特に実施上の観点から下
記のように分類する:
i) pH7.5〜13の範囲で最適作用を有するア
ルカリ性プロテアーゼ、特にアルカリ性細菌プロテアー
ゼ(E.C.3.4.21.)(大抵はセリン−タイプ
に属する)及びアルカリ性真菌プロテアーゼii)
pH6.0〜9.0の範囲で最適作用を有する、中性プ
ロテアーゼ、特に中性細菌プロテアーゼ(E.C.3.
4.24)(メタロ酵素に属する)及び真菌プロテアー
ゼ、例えばバシルス−プロテアーゼ(Basillus
−Proteasen)、プソイドモナス−プロテアー
ゼ(Pseudomonas−Proteasen)、
ストレプトマイセス−プロテアーゼ(Streptom
yces−Proteasen)、アスペルギルス−プ
ロテアーゼ(Aspergillus−Proteas
en)。Furthermore, the pH dependence of enzyme activity is of great practical importance. Therefore, particularly from a practical point of view, we classify: i) Alkaline proteases, especially alkaline bacterial proteases (E.C. 3.4.21.), with optimal action in the pH range 7.5-13 (mostly belongs to the serine-type) and alkaline fungal protease ii)
Neutral proteases, especially neutral bacterial proteases (E.C.3.
4.24) (belonging to metalloenzymes) and fungal proteases, e.g.
-Proteasen), Pseudomonas-Protease (Pseudomonas-Proteasen),
Streptomyces protease
yces-Proteasen), Aspergillus-Protease
en).
【0014】iii) pH2.0〜5.0の範囲で
最適作用を有する、酸性プロテアーゼ(E.C.3.4
.23)特に酸性真菌プロテアーゼ、例えばリゾプスs
pp.(Rhizopus spp.)、アスペルギ
ルスspp.(Aspergillus spp.)
、ペニシリウムspp.(Penicillinm
spp.)、ムコルspp.(Mucor spp.
)及びイムペックス ラクテウス(Impex I
acteus)及びエンドシチア パラシチカ(En
dothitia parasitica)。iii) Acidic protease (E.C. 3.4
.. 23) Especially acidic fungal proteases, such as Rhizopus s.
pp. (Rhizopus spp.), Aspergillus spp. (Aspergillus spp.)
, Penicillium spp. (Penicillinm
spp. ), Mucor spp. (Mucor spp.
) and Impex lacteus (Impex I
acteus) and Endosythia parasitica (En
dothia parasitica).
【0015】アルカリ性プロテアーゼとしては特に、p
H範囲9〜10で安定であり、過ほう酸塩に対してかな
り安定であるセリン−タイプのアルカリ性細菌プロテイ
ナーゼであるサブチリシンが挙げられる。[0015] As alkaline protease, p
Subtilisin is a serine-type alkaline bacterial proteinase that is stable in the H range of 9-10 and is fairly stable to perborate.
【0016】蛋白質分解酸素の使用は、約80年前にオ
ット−レーム(Otto Roehm)博士によりオ
ロボン(OROPON)(商品名)中に酵素酵解剤(膵
臓のトリプシン消化酵素)(西ドイツ特許第20051
9号明細書)が導入されて以来、皮革製造、特に水処理
場の確定成分である:酵解剤中での使用(西ドイツ特許
第927464号明細書;西ドイツ特許第976107
号明細書;西ドイツ特許第941811号明細書;西ド
イツ特許第974813号明細書;西ドイツ特許第97
5095号明細書;西ドイツ特許第976928号明細
書;西ドイツ特許第1120066号明細書;西ドイツ
特許第1134474号明細書;西ドイツ特許第121
9620号明細書;西ドイツ特許第1282837号明
細書;米国特許第3939040号明細書;米国特許第
4273876号明細書)の他に、酵素製剤は、柔軟剤
中でも(西ドイツ特許第288095号明細書;西ドイ
ツ特許第976662号明細書;西ドイツ特許第102
2748号明細書;西ドイツ特許第1034317号明
細書;西ドイツ特許第1282828号明細書;西ドイ
ツ特許第2059453号明細書;米国特許第4278
432号明細書;米国特許第4344762号明細書)
、更に毛弛緩(Haarlockerung)及び皮膨
脹(米国特許第4294087号明細書)に使用される
。The use of proteolytic oxygen was introduced approximately 80 years ago by Dr. Otto Roehm in OROPON (trade name), an enzymatic lysate (pancreatic tryptic enzyme) (West German Patent No. 20051).
Since its introduction (DE 927 464; DE 976 107) it has been a definite component in leather production, especially in water treatment plants: use in fermentation agents (DE 927 464; DE 976 107
Specification; West German Patent No. 941811; West German Patent No. 974813; West German Patent No. 97
West German Patent No. 5095; West German Patent No. 976928; West German Patent No. 1120066; West German Patent No. 1134474; West German Patent No. 121
Besides DE 9620; DE 1282837; US Pat. No. 3,939,040; US Pat. Patent No. 976662; West German Patent No. 102
West German Patent No. 1,034,317; West German Patent No. 1,282,828; West German Patent No. 2,059,453; US Pat. No. 4,278
432; U.S. Patent No. 4,344,762)
, and also for hair loosening and skin swelling (US Pat. No. 4,294,087).
【0017】酵素の蛋白分解作用は、通常アンソン−ヘ
モグロビン(Anson−Haemoglobin)法
(M.L.Anson J.Gen.Physiol
.第22巻、79頁、1939年)又はレーライン−フ
ォルハード(Loehlein−Volhard)法(
die Loehlein−Volhard′sch
e Methode zur Bestimmu
ng die Proteolytishen
Aktivitat.Gerbereichem.Ta
schenbuch Dresden−Leipzi
g、1955)により“LVE”[レーライン−フォル
ハード(Loehlein−Volhard)単位]と
して測定される。レーライン−フォルハード単位とは、
この方法の特定条件下でカゼイン1725mgが消費さ
れるような酵素量である(R.J.Beynon、J.
S.Bond、Proteolytic Enzym
esIRL press参照)。The proteolytic action of enzymes is usually carried out by the Anson-Haemoglobin method (M.L. Anson J. Gen. Physiol).
.. 22, p. 79, 1939) or the Loehlein-Volhard method (
die Loehlein-Volhard'sch
e Method zur Bestimmu
ng die Proteolytishen
Aktivitat. Gerbereichem. Ta
schenbuch Dresden-Leipzi
G., 1955) as “LVE” [Loehlein-Volhard units]. What is Lehline-Forhard unit?
The amount of enzyme is such that under the specific conditions of this method 1725 mg of casein is consumed (R.J. Beynon, J.
S. Bond, Proteolytic Enzyme
(see esIRL press).
【0018】更に、下記で活性測定用に、アンソン法か
ら誘導される酸性範囲で作用を有する酵素単位を使用す
る。これらは、“プロテイナーゼ単位”(ヘモグロビン
”Uнь)と称される。1Uньは、37℃で1分当り
にトリプシン1μモルに相応するヘモグロビンのトリク
ロル酢酸可溶性の部分の遊離を接触する(280nmで
測定して)酵素量に相応する[0018] Furthermore, in the following, enzyme units having an action in the acidic range derived from the Anson method are used for activity measurements. These are called "proteinase units" (hemoglobin). 1 unit contacts the release of the trichloroacetic acid-soluble part of hemoglobin corresponding to 1 μmol of trypsin per minute at 37°C (measured at 280 nm). ) corresponding to the amount of enzyme
【0019】[0019]
【外1】[Outside 1]
【0020】既に記載したように、本発明によるプロテ
イナーゼ製剤EPの製造は、有利には直接水性培地又は
酵素含有の液から出発して行う。As already mentioned, the production of the proteinase preparation EP according to the invention is advantageously carried out directly starting from an aqueous medium or an enzyme-containing solution.
【0021】その際、製剤EPを膵臓から製造すること
が特に有利である。It is particularly advantageous here to produce the preparation EP from the pancreas.
【0022】A.膵臓複合体からの製造本発明による方
法は、部分的には公知方法の単離法による(Ullma
nn、第4版、第10巻、上記引用文中536〜537
頁参照)。A. Preparation from pancreatic complexes The method according to the invention relies in part on isolation methods known in the art (Ullma et al.
nn, 4th edition, Volume 10, 536-537 in the above cited text
(see page).
【0023】単離は有利には、主として豚又は牛の膵臓
から屠殺後直ちに行う。Isolation is advantageously carried out immediately after slaughter, primarily from the pancreas of pigs or cows.
【0024】例えば、屠殺後直ちに腺から脂肪及び結合
組織をできる限りよく除去し、次いで例えば肉挽器を用
いて腺組織をホモジュネートすることによって、約10
0個の膵臓を1つのバッチに加工する。For example, by removing as much fat and connective tissue as possible from the glands immediately after slaughter and then homogenizing the glandular tissue using, for example, a meat grinder, about 10 min.
Process 0 pancreases into one batch.
【0025】その後直ちに、引き続いて、有利には約3
倍の容量(約60l)の0.25Nの硫酸で5℃で18
〜24時間抽出する。フィルターフロックの添加後に、
有利には包装用圧縮機で圧縮する。圧縮プレートは破棄
することができる。Immediately thereafter, advantageously about 3
18 at 5℃ with twice the volume (approximately 60L) of 0.25N sulfuric acid.
Extract for ~24 hours. After adding filter floc,
It is preferably compressed in a packaging press. The compression plate can be discarded.
【0026】こうして得られた十分に脂肪不含の圧搾酵
母汁はプロテイナーゼ製剤を製造するための出発物質で
ある。The sufficiently fat-free pressed yeast juice obtained in this way is the starting material for the production of proteinase preparations.
【0027】B.その他のプロテイナーゼ含有水性粗抽
出物からの製造
膵臓−圧搾酵母汁の代わりに、例えば真菌又は細菌培養
からのその他のプロテイナーゼ含有培養液を使用するこ
とができる(酵素起源に関する前記記載並びにUllm
ann、第4版、第10巻、518〜522頁、H.J
.Rehm、G.Reed Ed.Biotechn
ology第7a巻、156〜168頁、VCH198
7参照)。B. Production from other proteinase-containing aqueous crude extracts Instead of pancreatic-pressed yeast juice, other proteinase-containing broths can be used, for example from fungal or bacterial cultures (see above for the origin of the enzymes and Ullm.
Ann, 4th edition, Vol. 10, pp. 518-522, H. J
.. Rehm, G. Reed Ed. Biotechn
ology Vol. 7a, pp. 156-168, VCH198
(see 7).
【0028】培養液は−おおよその目安として−蛋白質
0.01〜3重量%を含有する。本発明による、作用酵
素としてのプロテイナーゼを含有する、界面活性剤不含
の粉末状又は顆粒形の固体酵素製剤EPの製造は、下記
のようにして行うことができる:先ず、沈澱剤の正しい
添加が重要であると判明した。タンニンの使用が不十分
である場合には、沈澱は不完全であり、過剰に使用する
場合には、生成されたタンニン複合体は消散しにくい。
上澄み液中になお0.5〜3%の酵素活性が存在するよ
うな量の沈澱剤を使用することが有利な技術的原則であ
ると実証された。即ち、例えば膵臓−圧縮液(活性蛋白
質約2重量%を含有する)から沈澱させる場合には、有
利にミモザ−なめし剤4重量%を使用する。一般に、タ
ンニン複合体中の蛋白質含量は、10〜80重量%であ
る。The culture medium contains - as a rough guide - 0.01-3% by weight of protein. The production of a surfactant-free powdered or granular solid enzyme preparation EP containing a proteinase as active enzyme according to the invention can be carried out as follows: first, the correct addition of the precipitant; was found to be important. If insufficient tannins are used, the precipitation is incomplete, and if excessively used, the tannin complexes produced are difficult to dissipate. It has proven to be an advantageous technical principle to use such an amount of precipitant that there is still 0.5-3% enzyme activity in the supernatant. Thus, for example, in the case of precipitation from pancreatic compress (which contains approximately 2% by weight of active protein), 4% by weight of mimosa tanning agent is preferably used. Generally, the protein content in the tannin complex is 10-80% by weight.
【0029】詳細には、低いpH値の水性液を製造する
のが有利である(その際、もちろん当該プロテアーゼの
安定性に留意する)。目安としては約3〜6のpH値が
挙げられ、培養液又は膵臓は大抵約6のpH値を有する
。pH=7より上での沈澱はあまり有利ではない。どの
場合でも低い温度(<20℃)の使用が有利である。
更にHLB値<6を有する水に不溶性の界面活性剤の添
加が有利であると実証された。この種の界面活性剤は、
例えば長鎖のエステル、例えばソルビタン脂肪酸エステ
ルの群から選択される。例えば、ソルビタンモノオクタ
デカネート等が挙げられる。この種の界面活性剤は市販
されており、例えば、アトラスヒェミー社(Fa.AT
LAS Chemie、Essen)のTyp S
PAN(商品名)の製品を参照にされたい。[0029] In particular, it is advantageous to prepare aqueous solutions with low pH values (taking into account, of course, the stability of the protease in question). A guideline is a pH value of about 3 to 6, with the culture fluid or pancreas usually having a pH value of about 6. Precipitation above pH=7 is less advantageous. The use of low temperatures (<20° C.) is advantageous in all cases. Furthermore, the addition of water-insoluble surfactants with an HLB value <6 has proven advantageous. This type of surfactant is
For example selected from the group of long chain esters, such as sorbitan fatty acid esters. For example, sorbitan monooctadecanate and the like can be mentioned. Surfactants of this type are commercially available, for example Atlas Chemie (Fa.AT)
LAS Chemie, Essen) Type S
Please refer to the product PAN (product name).
【0030】定義によれば、酵素製剤の塩含量は、少な
くとも50重量%が増量剤として常用の1種又は数種の
塩から成る。これらの塩には有利には硫酸アンモン又は
硫酸ナトリウムが該当する。By definition, the salt content of the enzyme preparation consists of at least 50% by weight of one or more salts commonly used as fillers. These salts are preferably ammonium sulfate or sodium sulfate.
【0031】有利な作用
有利な作用は、本発明による酵素製剤EPの使用はもち
ろんのこと、既に製造及び取扱上の観点にもあてはまる
。Advantageous Effects The advantageous effects apply not only to the use of the enzyme preparation EP according to the invention, but also to the production and handling aspects.
【0032】タンニン複合体の製造は、非常に効果的で
同時に選択的な沈澱法であるので、資源を非常に良好に
利用するものである。主に実施されている塩沈澱法に比
べて、“母液”による環境汚染が著しく僅かであること
が際だっている。酵素製剤はほこりがでず、皮膚に対し
てアレルギー作用を示さないので、作業衛生的にも“改
善”として評価される。The production of tannin complexes is a very efficient and at the same time selective precipitation method and therefore makes very good use of resources. Compared to the commonly practiced salt precipitation methods, it is notable that the environmental pollution caused by the "mother liquor" is significantly lower. Enzyme preparations do not generate dust and do not have allergic effects on the skin, so they are evaluated as an "improvement" in terms of work hygiene.
【0033】使用上の観点で、本発明による酵素製剤は
、伝統的な工業的取扱内で使用することができ、即ち、
水処理場での工程の根本的な変更を必要としない。
本発明による酵素製剤EPの使用は、特に、伝統的な酵
素により助成される柔軟剤及び酵解剤中で有効であるこ
とが実証された。その際、タンニン複合体の“消散(A
nfgehen)”を助成するので、使用pH値が高い
こと(pH>8)が特に有利である。In terms of use, the enzyme preparation according to the invention can be used within traditional industrial handling, ie:
Does not require fundamental changes to the process at the water treatment plant. The use of the enzyme preparation EP according to the invention has proven particularly effective in traditional enzyme-assisted softeners and fermenters. At that time, “dissipation (A
It is particularly advantageous for the pH used to be high (pH>8), as this promotes "nfgehen)".
【0034】使用:柔軟剤の実施
塩蔵時に起こる皮の硬化を元に戻すための皮材料の柔軟
化は、一般にpH>7.0〜10.0で実施される。酵
素、特に蛋白質分解酵素を一緒に使用することにより、
この柔軟化作用は、皮のコラーゲン繊維組織に属さない
水溶性のその他の蛋白体の“消化”によって助成される
。一般に、柔軟剤中でpH7.0〜10.0で作用範囲
(又は蛋白質分解作用の最適pH値)を有する酵素を使
用する。非コラーゲン蛋白質の除去に伴って、皮膚の迅
速で強力な湿潤が保証される。有利には、柔軟水をアル
カリ性に調製する(前記参照)が、pH値は常に<12
に保つべきである。更に、柔軟助剤(例えば非イオン性
及び陰イオン性界面活性剤)を、置換されたフェノール
又はジチオカルバメートと常用の濃度範囲(0.1〜1
0g/l)で組み合わせることが有利である。本発明に
よる酵素製剤中の酵素添加物としては、例えば前記プロ
テアーゼ、特にc)に挙げたプロテアーゼが挙げられる
:特に作用範囲7〜11.0の微生物プロテアーゼ、特
にバチルスプロテアーゼ、ストレプトマイセスプロテア
ーゼ並びに菌プロテアーゼ、例えばアスペルギルス類、
例えばA.サイトイ(A.saitoi)及びA.ウサ
ミイ(A.usamii)、更に例えばpH作用範囲7
.0〜9.5を有するA.オリザエ(A.oryzae
)、更にpH作用範囲9.5〜11.0を有するA.ニ
ゲル(A.niger)及びA.フラブス(A.fla
vus)からのもの。Use: Implementation of Softeners Softening of the skin material to reverse the hardening of the skin that occurs during salting is generally carried out at a pH>7.0 to 10.0. By using together enzymes, especially proteolytic enzymes,
This softening effect is aided by the "digestion" of other water-soluble proteins that do not belong to the skin's collagen fiber tissue. Generally, enzymes are used that have an active range (or optimum pH value for proteolytic action) at pH 7.0 to 10.0 in softeners. With the removal of non-collagen proteins, rapid and intense moisturization of the skin is ensured. Advantageously, the softening water is prepared alkaline (see above), but the pH value is always <12
should be kept at Additionally, softening aids (e.g. nonionic and anionic surfactants) can be combined with substituted phenols or dithiocarbamates in a conventional concentration range (0.1-1
0 g/l). Enzyme additives in the enzyme preparations according to the invention include, for example, the proteases mentioned above, in particular the proteases mentioned under c): in particular microbial proteases with an action range of 7 to 11.0, in particular Bacillus protease, Streptomyces protease and Bacterium proteases. Proteases, such as Aspergillus,
For example, A. A. saitoi and A. saitoi. A. usamii, further e.g. pH working range 7
.. A. having a value of 0 to 9.5. A. oryzae
), and A. A. niger and A. niger. Flavus (A. fla)
Vus).
【0035】一般に、使用されるプロテイナーゼの蛋白
質分解作用の濃度は、柔軟汁1l当り0.01〜0.0
3アンソン単位又は1000〜3000レーライン−フ
ォルハード単位である。従って、酵素製剤EPの使用量
は、その酵素含量の程度によりこれらの濃度に相応する
。最後に、柔軟汁はアミラーゼを含有することができる
。アミラーゼは例えば菌プロテイナーゼの随伴酵素であ
る。アミラーゼは、皮膚のプロテオグリカン及びグリコ
プロテインでグリコシド結合の分解を助成する。Generally, the proteolytic concentration of the proteinase used is 0.01 to 0.0 per liter of softening juice.
3 Anson units or 1000 to 3000 Lehlein-Forhard units. Therefore, the amount of enzyme preparation EP to be used will correspond to these concentrations depending on the extent of its enzyme content. Finally, softener juices can contain amylase. Amylase is, for example, a companion enzyme to fungal proteinases. Amylase assists in the breakdown of glycosidic bonds in skin proteoglycans and glycoproteins.
【0036】柔軟化に引き続いて、水処理場の工程では
、一般に石灰液処理、次いで脱灰及び−主として酵素に
よる−酵解を行う。Following softening, water treatment plant processes generally include lime treatment followed by demineralization and - primarily enzymatic - fermentation.
【0037】この工程でも、酵素製剤EPを有利に使用
することができる。[0037] Also in this step, the enzyme preparation EP can be advantageously used.
【0038】使用:酵解
脱灰は伝統的に、生皮のアルカリ度を13〜14のpH
値から7〜8の範囲のpH値に下げるために役立つ。脱
灰するために、有利には例えばジカルボン酸の種類の強
く解離したものではなく、弱い有機酸又は弱酸性の塩を
使用する。酵解時に、表皮−、毛−及び色素残分を除去
し、付加的な皮溶解を起こすべきである。更に、非コラ
ーゲンの蛋白質成分を除去する(Ullmann、第4
版、第16巻、前記参照、119〜120頁)。酵解時
には、一般にpH7.5〜8.5で操作する。西ドイツ
特許(DE−A)第3108428号明細書から環式カ
ルボネートを脱灰で使用することが公知である。Use: Fermentation and demineralization traditionally reduce the alkalinity of rawhide to a pH of 13-14.
It helps to lower the pH value from 7 to 8. For deashing, preference is given to using weak organic acids or weakly acidic salts rather than strongly dissociated ones, for example of the dicarboxylic acid type. During fermentation, epidermal, hair and pigment residues should be removed and additional skin lysis should occur. Additionally, non-collagen protein components are removed (Ullmann, vol. 4).
Edition, Vol. 16, supra, pp. 119-120). During fermentation, the pH is generally 7.5 to 8.5. The use of cyclic carbonates in deashing is known from DE-A 31 08 428.
【0039】同時に酵解時には、pH7.0〜9.0で
作用範囲を有するリパーゼ、例えば膵臓−リパーゼを使
用することができる。pH5.5〜8.5で作用範囲を
有するB.によるアミラーゼ、例えば膵臓−アミラーゼ
(これらは酵解でグリコシド結合の分解を助成する)も
、(特にトリプシン及びキモトリプシンの随伴酵素とし
て)酵解に対して有利な影響を与える。At the same time, during the fermentation it is possible to use lipases having an action range between pH 7.0 and 9.0, such as pancreatic lipase. B. has an active range between pH 5.5 and 8.5. Amylases such as pancreatic amylases, which assist in the breakdown of glycosidic bonds in fermentation, also have a beneficial influence on fermentation (in particular as companion enzymes for trypsin and chymotrypsin).
【0040】次に本発明を実施例につき詳説する。Next, the present invention will be explained in detail with reference to examples.
【0041】[0041]
【実施例】例 1
膵臓からの製剤の製造
脂肪除去した膵腺からの蛋白質0.4%を含有する濾液
100kgに、撹はん下、室温で、水20kg中のネム
リグサからのなめし剤5kgの溶液を加える。直ちに生
じた蛋白質の沈澱を2時間室温(20℃)で更に撹はん
し、次いで濾過する。フィルターケーキをパックプレス
(Packpress)で圧縮し、次いで前粉砕する。
次いで温度60〜80℃で注意深く乾燥させ、1:10
で硫酸アンモニウムと混合する。EXAMPLES Example 1 Preparation of preparations from pancreas 100 kg of filtrate containing 0.4% protein from defatted pancreatic glands were mixed with 5 kg of tanning agent from Nastyrida in 20 kg of water under stirring at room temperature. Add solution. The immediately formed protein precipitate is further stirred for 2 hours at room temperature (20° C.) and then filtered. The filter cake is compressed in a Packpress and then pre-milled. Then carefully dry at a temperature of 60-80℃, 1:10
Mix with ammonium sulfate.
【0042】得られた混合物は、直ちに、革柔軟剤、革
酵解剤中に、脱毛するために及びウェットブルー(We
tblues)の弛緩のために使用することができる。The resulting mixture is immediately added to leather softeners, leather decomposers for depilation and wet blue (Wet Blue).
tblues) can be used for relaxation.
【0043】例 2
A.オリザエ酵母からの製剤の製造
菌培養から限外濾過により蛋白質約2%を含有するプロ
テイナーゼ濃縮物を得、+15℃に冷却する。沈澱性を
改善するために、濃縮物にSPAN 40(Atla
sChemie、Essenの製品の商品名)100g
、引き続いて水16kg中のネムリグサ−なめし剤4k
gを加える。直ちに蛋白質の沈澱が起こる。1時間放置
後、バッチをパーライトを基礎とした濾過助剤(DIC
ALITE 4408、Fa.Dicalite、N
euβ)2kgの添加下で濾過する(1時間及びフィル
ター面積1m2当り60〜80l)。圧縮したフィルタ
ーケーキを注意深く乾燥させ(60〜80℃)、1:3
0の比で硫酸ナトリウム及び硫酸アンモニウムから成る
混合物を加える。Example 2 A. Preparation of preparations from Y. oryzae yeast A proteinase concentrate containing approximately 2% protein is obtained from the bacterial culture by ultrafiltration and cooled to +15°C. To improve sedimentation, the concentrate was coated with SPAN 40 (Atla
sChemie, trade name of Essen product) 100g
, followed by 4k of Nemurixa tanning agent in 16kg of water.
Add g. Protein precipitation occurs immediately. After standing for 1 hour, the batch was treated with a perlite-based filter aid (DIC).
ALITE 4408, Fa. Dicalite, N
euβ) (60-80 l/m2 of filter area for 1 hour). Carefully dry the compressed filter cake (60-80°C) and mix 1:3
Add a mixture consisting of sodium sulfate and ammonium sulfate in a ratio of 0.
【0044】得られた混合物は直ちに革柔軟剤、革酵解
剤中に、脱毛するために及びエウェットブルーの弛緩の
ために使用することができる。The mixture obtained can be used immediately in leather softeners, leather decomposers, for depilation and for relaxing ewett blue.
Claims (8)
ンニン複合体として、この酵素製剤EPが、増量剤とし
て自体慣用の1種又は数種の塩少なくとも50重量%及
び99.9重量%までから成るような程度で存在するこ
とを特徴とする、作用酵素としてのプロテアーゼを含有
することを特徴とする、界面活性剤不含の粉末状又は顆
粒状酵素製剤。1. The protease is present as a tannin complex in the enzyme preparation EP, which enzyme preparation EP consists of at least 50% by weight and up to 99.9% by weight of one or more salts customary per se as fillers. A surfactant-free powder or granular enzyme preparation, characterized in that it contains protease as active enzyme, characterized in that it is present in such a degree.
トリウムから成ることを特徴とする、請求項1に記載の
酵素製剤EP。2. Enzyme preparation EP according to claim 1, characterized in that the bulking agent consists of ammonium sulfate or sodium sulfate.
することを特徴とする、酵素的柔軟剤。3. An enzymatic softener containing the enzyme preparation EP according to claim 1.
することを特徴とする、酵素的酵解剤。4. An enzymatic fermentation agent containing the enzyme preparation EP according to claim 1.
−pH値>7〜11で使用することを特徴とする酵素的
柔軟剤。5. Enzymatic softener, characterized in that the enzyme preparation EP according to claim 3 is used at a starting pH value of >7-11.
−pH値>8〜11で使用することを特徴とする酵素的
柔軟剤。6. Enzymatic softener, characterized in that the enzyme preparation EP according to claim 5 is used at a starting pH value of >8-11.
−pH値>5〜11で使用することを特徴とする酵素的
酵解剤。7. Enzymatic fermentation agent, characterized in that the enzyme preparation EP according to claim 4 is used at a starting pH value of >5 to 11.
−pH値6〜9で使用することを特徴とする酵素的酵解
剤。8. An enzymatic fermentation agent, characterized in that the enzyme preparation EP according to claim 7 is used at a starting pH value of 6 to 9.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4035839A DE4035839A1 (en) | 1990-11-10 | 1990-11-10 | PROTEASE AS A ACTIVE ENZYME, TENSIDE-FREE, FIXED ENZYMERS |
DE4035839.9 | 1990-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04273000A true JPH04273000A (en) | 1992-09-29 |
Family
ID=6418031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3291064A Pending JPH04273000A (en) | 1990-11-10 | 1991-11-07 | Powdery or granular enzyme preparation which contains protease as working enzyme and does not contain surface active agent, and enzymatic softening agent and bating agent which contain the preparation |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPH04273000A (en) |
DE (1) | DE4035839A1 (en) |
DK (1) | DK177791A (en) |
ES (1) | ES2037603B1 (en) |
GB (1) | GB2250289B (en) |
IT (1) | IT1250027B (en) |
NL (1) | NL9101869A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0209303B1 (en) * | 2001-05-01 | 2011-10-04 | process to improve softness and / or leather area yield. | |
US7985569B2 (en) | 2003-11-19 | 2011-07-26 | Danisco Us Inc. | Cellulomonas 69B4 serine protease variants |
US8535927B1 (en) | 2003-11-19 | 2013-09-17 | Danisco Us Inc. | Micrococcineae serine protease polypeptides and compositions thereof |
US7618801B2 (en) | 2007-10-30 | 2009-11-17 | Danison US Inc. | Streptomyces protease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE128419C (en) * | 1900-01-01 | |||
DD87754A (en) * | ||||
DE1642619A1 (en) * | 1968-02-07 | 1971-01-21 | Forsch Die Gaerungsindustrie E | Process for the production of enzyme or protein dry preparations |
GB1156900A (en) * | 1968-06-14 | 1969-07-02 | Dresden Arzneimittel | Process for the Isolation of Enzymes |
DE2143945B2 (en) * | 1971-09-02 | 1979-11-15 | Kali Chemie Ag | Use of an enzyme adduct in detergents and cleaning agents |
IT1011668B (en) * | 1973-04-28 | 1977-02-10 | Roehm Gmbh | PROCEDURE OF PURGE OF THE SKINS |
DE2929844A1 (en) * | 1979-07-23 | 1981-02-26 | Roehm Gmbh | SOFT METHOD |
-
1990
- 1990-11-10 DE DE4035839A patent/DE4035839A1/en not_active Ceased
-
1991
- 1991-10-25 DK DK177791A patent/DK177791A/en not_active Application Discontinuation
- 1991-10-29 IT ITTO910815A patent/IT1250027B/en active IP Right Grant
- 1991-11-07 GB GB9123714A patent/GB2250289B/en not_active Expired - Fee Related
- 1991-11-07 ES ES9102467A patent/ES2037603B1/en not_active Expired - Lifetime
- 1991-11-07 JP JP3291064A patent/JPH04273000A/en active Pending
- 1991-11-08 NL NL9101869A patent/NL9101869A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2037603A1 (en) | 1993-06-16 |
ITTO910815A0 (en) | 1991-10-29 |
DK177791A (en) | 1992-05-11 |
GB2250289A (en) | 1992-06-03 |
DK177791D0 (en) | 1991-10-25 |
IT1250027B (en) | 1995-03-30 |
NL9101869A (en) | 1992-06-01 |
ES2037603B1 (en) | 1994-02-01 |
GB9123714D0 (en) | 1992-01-02 |
ITTO910815A1 (en) | 1993-04-29 |
DE4035839A1 (en) | 1992-05-14 |
GB2250289B (en) | 1994-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960016075B1 (en) | Liquid composition for enzymes and method for leather processing and bleaching | |
Suh et al. | Characterization of a keratinolytic serine protease from Bacillus subtilis KS-1 | |
Sundus et al. | Industrial applications and production sources of serine alkaline proteases: a review | |
Karn et al. | Hydrolytic enzyme protease in sludge: recovery and its application | |
US3939040A (en) | Enzymatic bating method | |
AU2003217445B2 (en) | Total lime and sulfide free unhairing process using animal and/or plant enzymes | |
JPH01502477A (en) | alkaline serine protease | |
RU2052506C1 (en) | Method of treatment of hide and depilated hide | |
US20130115671A1 (en) | Enzymes from conidiobolus brefeldianus and process for preparation thereof | |
JPH04273000A (en) | Powdery or granular enzyme preparation which contains protease as working enzyme and does not contain surface active agent, and enzymatic softening agent and bating agent which contain the preparation | |
JPH0398580A (en) | Preparation of aqeous compositions of protein degrading enzyme having sufficient stability | |
US6451586B1 (en) | Enzyme preparation containing protease | |
Salleh et al. | Protease: introduction | |
US20080220499A1 (en) | Novel protease for industrial applications | |
JP3592811B2 (en) | Low-temperature active alkaline protease, microorganism producing the same, and method for producing the alkaline protease | |
KR100329962B1 (en) | a protease which degrades keratin layers of skin surface, a microorganism which produces the protease and a cosmetic composition containing a culture solution thereof. | |
JP3592795B2 (en) | Low-temperature optimal alkaline protease, microorganism producing the same, and method for producing the alkaline protease | |
Khandelwal | Production, purification and characterization of fungal alkaline protease and its applications | |
JP3595024B2 (en) | Low-temperature optimal protease, microorganism producing the same, and method for producing the protease | |
Zambare et al. | Proteases in Leather Processing | |
Mian | Optimization of alkaline protease production by Bacillus licheniformis MZK05M9 in batch culture using response surface methodology | |
WO2020234760A1 (en) | Bacterial strains for industrial use | |
JP3664800B2 (en) | Low-temperature alkaline protease T15, microorganism producing the same, method for producing the same, detergent composition containing the enzyme, and enzyme preparation for food processing | |
Kumar et al. | Protease-an important enzyme in detergent industry | |
JPH09299084A (en) | Low-temperature alkali protease, microorganism capable of producing the same, production of the same, and detergent composition containing the enzyme and enzyme preparation for food processing |